Response surface model for anesthetic drug interactions
Anesthetic drug interactions traditionally have been characterized using isobolographic analysis or multiple logistic regression. Both approaches have significant limitations. The authors propose a model based on response-surface methodology. This model can characterize the entire dose-response rela...
Gespeichert in:
Veröffentlicht in: | Anesthesiology (Philadelphia) 2000-06, Vol.92 (6), p.1603-1616 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1616 |
---|---|
container_issue | 6 |
container_start_page | 1603 |
container_title | Anesthesiology (Philadelphia) |
container_volume | 92 |
creator | MINTO, C. F SCHNIDER, T. W SHORT, T. G GREGG, K. M GENTILINI, A SHAFER, S. L |
description | Anesthetic drug interactions traditionally have been characterized using isobolographic analysis or multiple logistic regression. Both approaches have significant limitations. The authors propose a model based on response-surface methodology. This model can characterize the entire dose-response relation between combinations of anesthetic drugs and is mathematically consistent with models of the concentration-response relation of single drugs.
The authors defined a parameter, theta, that describes the concentration ratio of two potentially interacting drugs. The classic sigmoid Emax model was extended by making the model parameters dependent on theta. A computer program was used to estimate response surfaces for the hypnotic interaction between midazolam, propofol, and alfentanil, based on previously published data. The predicted time course of effect was simulated after maximally synergistic bolus dose combinations.
The parameters of the response surface were identifiable. With the test data, each of the paired combinations showed significant synergy. Computer simulations based on interactions at the effect site predicted that the maximally synergistic three-drug combination tripled the duration of effect compared with propofol alone.
Response surfaces can describe anesthetic interactions, even those between agonists, partial agonists, competitive antagonists, and inverse agonists. Application of response-surface methodology permits characterization of the full concentration-response relation and therefore can be used to develop practical guidelines for optimal drug dosing. |
doi_str_mv | 10.1097/00000542-200006000-00017 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00000542_200006000_00017</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10839909</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-7fe87becf741a6ad1ad441812fabb3b2713e9a41ef9d6ac2500b984f0896e7a63</originalsourceid><addsrcrecordid>eNpNkE1LAzEQhoMotlb_guTgNZpJdjfJUYpWoSCInpfZ7ERX2t2SbA_-e1NbPwaG-eB5B-ZljIO8BunMjdxFWSihdk2VU-QEc8SmUCorAEx5zKZ5p4WWSk3YWUofeTSltqdsAtJq56SbMvNMaTP0iXjaxoCe-HpoacXDEDn2lMZ3GjvP27h9410_UkQ_dpk_ZycBV4kuDnXGXu_vXuYPYvm0eJzfLoXXTo7CBLKmIR9MAVhhC9gWBVhQAZtGN8qAJocFUHBthV6VUjbOFkFaV5HBSs-Y3d_1cUgpUqg3sVtj_KxB1jsv6h8v6l8v6m8vsvRyL91smzW1_4T75zNwdQAweVyFiL3v0h-nnbXO6C-yXmak</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Response surface model for anesthetic drug interactions</title><source>Journals@Ovid Ovid Autoload</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>MINTO, C. F ; SCHNIDER, T. W ; SHORT, T. G ; GREGG, K. M ; GENTILINI, A ; SHAFER, S. L</creator><creatorcontrib>MINTO, C. F ; SCHNIDER, T. W ; SHORT, T. G ; GREGG, K. M ; GENTILINI, A ; SHAFER, S. L</creatorcontrib><description>Anesthetic drug interactions traditionally have been characterized using isobolographic analysis or multiple logistic regression. Both approaches have significant limitations. The authors propose a model based on response-surface methodology. This model can characterize the entire dose-response relation between combinations of anesthetic drugs and is mathematically consistent with models of the concentration-response relation of single drugs.
The authors defined a parameter, theta, that describes the concentration ratio of two potentially interacting drugs. The classic sigmoid Emax model was extended by making the model parameters dependent on theta. A computer program was used to estimate response surfaces for the hypnotic interaction between midazolam, propofol, and alfentanil, based on previously published data. The predicted time course of effect was simulated after maximally synergistic bolus dose combinations.
The parameters of the response surface were identifiable. With the test data, each of the paired combinations showed significant synergy. Computer simulations based on interactions at the effect site predicted that the maximally synergistic three-drug combination tripled the duration of effect compared with propofol alone.
Response surfaces can describe anesthetic interactions, even those between agonists, partial agonists, competitive antagonists, and inverse agonists. Application of response-surface methodology permits characterization of the full concentration-response relation and therefore can be used to develop practical guidelines for optimal drug dosing.</description><identifier>ISSN: 0003-3022</identifier><identifier>EISSN: 1528-1175</identifier><identifier>DOI: 10.1097/00000542-200006000-00017</identifier><identifier>PMID: 10839909</identifier><identifier>CODEN: ANESAV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Algorithms ; Anesthetics - pharmacokinetics ; Anesthetics - pharmacology ; Anesthetics. Neuromuscular blocking agents ; Biological and medical sciences ; Computer Simulation ; Dose-Response Relationship, Drug ; Drug Interactions ; Humans ; Medical sciences ; Models, Theoretical ; Neuropharmacology ; Pharmacology. Drug treatments</subject><ispartof>Anesthesiology (Philadelphia), 2000-06, Vol.92 (6), p.1603-1616</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-7fe87becf741a6ad1ad441812fabb3b2713e9a41ef9d6ac2500b984f0896e7a63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1398897$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10839909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MINTO, C. F</creatorcontrib><creatorcontrib>SCHNIDER, T. W</creatorcontrib><creatorcontrib>SHORT, T. G</creatorcontrib><creatorcontrib>GREGG, K. M</creatorcontrib><creatorcontrib>GENTILINI, A</creatorcontrib><creatorcontrib>SHAFER, S. L</creatorcontrib><title>Response surface model for anesthetic drug interactions</title><title>Anesthesiology (Philadelphia)</title><addtitle>Anesthesiology</addtitle><description>Anesthetic drug interactions traditionally have been characterized using isobolographic analysis or multiple logistic regression. Both approaches have significant limitations. The authors propose a model based on response-surface methodology. This model can characterize the entire dose-response relation between combinations of anesthetic drugs and is mathematically consistent with models of the concentration-response relation of single drugs.
The authors defined a parameter, theta, that describes the concentration ratio of two potentially interacting drugs. The classic sigmoid Emax model was extended by making the model parameters dependent on theta. A computer program was used to estimate response surfaces for the hypnotic interaction between midazolam, propofol, and alfentanil, based on previously published data. The predicted time course of effect was simulated after maximally synergistic bolus dose combinations.
The parameters of the response surface were identifiable. With the test data, each of the paired combinations showed significant synergy. Computer simulations based on interactions at the effect site predicted that the maximally synergistic three-drug combination tripled the duration of effect compared with propofol alone.
Response surfaces can describe anesthetic interactions, even those between agonists, partial agonists, competitive antagonists, and inverse agonists. Application of response-surface methodology permits characterization of the full concentration-response relation and therefore can be used to develop practical guidelines for optimal drug dosing.</description><subject>Algorithms</subject><subject>Anesthetics - pharmacokinetics</subject><subject>Anesthetics - pharmacology</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Biological and medical sciences</subject><subject>Computer Simulation</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Interactions</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Models, Theoretical</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><issn>0003-3022</issn><issn>1528-1175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkE1LAzEQhoMotlb_guTgNZpJdjfJUYpWoSCInpfZ7ERX2t2SbA_-e1NbPwaG-eB5B-ZljIO8BunMjdxFWSihdk2VU-QEc8SmUCorAEx5zKZ5p4WWSk3YWUofeTSltqdsAtJq56SbMvNMaTP0iXjaxoCe-HpoacXDEDn2lMZ3GjvP27h9410_UkQ_dpk_ZycBV4kuDnXGXu_vXuYPYvm0eJzfLoXXTo7CBLKmIR9MAVhhC9gWBVhQAZtGN8qAJocFUHBthV6VUjbOFkFaV5HBSs-Y3d_1cUgpUqg3sVtj_KxB1jsv6h8v6l8v6m8vsvRyL91smzW1_4T75zNwdQAweVyFiL3v0h-nnbXO6C-yXmak</recordid><startdate>20000601</startdate><enddate>20000601</enddate><creator>MINTO, C. F</creator><creator>SCHNIDER, T. W</creator><creator>SHORT, T. G</creator><creator>GREGG, K. M</creator><creator>GENTILINI, A</creator><creator>SHAFER, S. L</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20000601</creationdate><title>Response surface model for anesthetic drug interactions</title><author>MINTO, C. F ; SCHNIDER, T. W ; SHORT, T. G ; GREGG, K. M ; GENTILINI, A ; SHAFER, S. L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-7fe87becf741a6ad1ad441812fabb3b2713e9a41ef9d6ac2500b984f0896e7a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Algorithms</topic><topic>Anesthetics - pharmacokinetics</topic><topic>Anesthetics - pharmacology</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Biological and medical sciences</topic><topic>Computer Simulation</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Interactions</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Models, Theoretical</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MINTO, C. F</creatorcontrib><creatorcontrib>SCHNIDER, T. W</creatorcontrib><creatorcontrib>SHORT, T. G</creatorcontrib><creatorcontrib>GREGG, K. M</creatorcontrib><creatorcontrib>GENTILINI, A</creatorcontrib><creatorcontrib>SHAFER, S. L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Anesthesiology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MINTO, C. F</au><au>SCHNIDER, T. W</au><au>SHORT, T. G</au><au>GREGG, K. M</au><au>GENTILINI, A</au><au>SHAFER, S. L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response surface model for anesthetic drug interactions</atitle><jtitle>Anesthesiology (Philadelphia)</jtitle><addtitle>Anesthesiology</addtitle><date>2000-06-01</date><risdate>2000</risdate><volume>92</volume><issue>6</issue><spage>1603</spage><epage>1616</epage><pages>1603-1616</pages><issn>0003-3022</issn><eissn>1528-1175</eissn><coden>ANESAV</coden><abstract>Anesthetic drug interactions traditionally have been characterized using isobolographic analysis or multiple logistic regression. Both approaches have significant limitations. The authors propose a model based on response-surface methodology. This model can characterize the entire dose-response relation between combinations of anesthetic drugs and is mathematically consistent with models of the concentration-response relation of single drugs.
The authors defined a parameter, theta, that describes the concentration ratio of two potentially interacting drugs. The classic sigmoid Emax model was extended by making the model parameters dependent on theta. A computer program was used to estimate response surfaces for the hypnotic interaction between midazolam, propofol, and alfentanil, based on previously published data. The predicted time course of effect was simulated after maximally synergistic bolus dose combinations.
The parameters of the response surface were identifiable. With the test data, each of the paired combinations showed significant synergy. Computer simulations based on interactions at the effect site predicted that the maximally synergistic three-drug combination tripled the duration of effect compared with propofol alone.
Response surfaces can describe anesthetic interactions, even those between agonists, partial agonists, competitive antagonists, and inverse agonists. Application of response-surface methodology permits characterization of the full concentration-response relation and therefore can be used to develop practical guidelines for optimal drug dosing.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>10839909</pmid><doi>10.1097/00000542-200006000-00017</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-3022 |
ispartof | Anesthesiology (Philadelphia), 2000-06, Vol.92 (6), p.1603-1616 |
issn | 0003-3022 1528-1175 |
language | eng |
recordid | cdi_crossref_primary_10_1097_00000542_200006000_00017 |
source | Journals@Ovid Ovid Autoload; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Algorithms Anesthetics - pharmacokinetics Anesthetics - pharmacology Anesthetics. Neuromuscular blocking agents Biological and medical sciences Computer Simulation Dose-Response Relationship, Drug Drug Interactions Humans Medical sciences Models, Theoretical Neuropharmacology Pharmacology. Drug treatments |
title | Response surface model for anesthetic drug interactions |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T03%3A46%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20surface%20model%20for%20anesthetic%20drug%20interactions&rft.jtitle=Anesthesiology%20(Philadelphia)&rft.au=MINTO,%20C.%20F&rft.date=2000-06-01&rft.volume=92&rft.issue=6&rft.spage=1603&rft.epage=1616&rft.pages=1603-1616&rft.issn=0003-3022&rft.eissn=1528-1175&rft.coden=ANESAV&rft_id=info:doi/10.1097/00000542-200006000-00017&rft_dat=%3Cpubmed_cross%3E10839909%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10839909&rfr_iscdi=true |